Liver cancer death rates among adults continue to climb across the U.S., according to new research from the Centers for Disease Control and Prevention (CDC).

A Cleveland-based startup called XaTek has developed a handheld device that can inform users or physicians about their blood’s clotting ability within 30 minutes.

Hospital utilization is slowing down in its growth, according to a recent survey of hospital administrators. The trend underscores the shift across the healthcare system away from high-cost settings toward lower-cost outpatient utilization.

Secondary interpretations of diagnostic imaging examinations have increased significantly among Medicare beneficiaries, according to a new study published by the Journal of the American College of Radiology. The authors also noted that denial rates for these secondary interpretations are “uniformly low.”

ROCHESTER, New York,— Hurley Medical Center in Flint, Michigan purchased a Carestream DRX-Ascend system, two Carestream DRX-Revolution mobile x-ray systems and upgraded three portable x-ray systems that serve the ER, NICU and general radiology department.

Royal Philips, a global leader in health technology, today announced it has signed two long-term strategic partnership agreements with hospital groups in Germany.

SAN CARLOS, Calif., July 17, 2018 — BAROnova, Inc., announced today that it has submitted a Pre-Market Approval (PMA) application for the TransPyloric Shuttle device intended for the treatment of obesity to the Food and Drug Administration (FDA).

In May, the Cleveland Clinic hired David Flannery, MD, as its director of digital genetics for the Center for Personalized Genetic Healthcare—with a specific goal of boosting telegenetic offerings. A pied piper of telemedicine for decades, Flannery believes it can help meet demand and control costs. 

The American Medical Informatics Association announced a new fellow program to recognize leading members in informatics skill and knowledge. The Fellow of AMIA Applied Informatics Recognition Program will foster growth members who have demonstrated leadership in the betterment of the AMIA.

Low doses (75-100 mg per day) of aspirin were found to be ineffective for people above 154 pounds, while higher doses only reduced cardiovascular events among patients with greater body size.